AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Brivaracetam 50 Mg ;

15 registrations across 1 African market— 15 active

Markets with Brivaracetam 50 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Varocetam 50 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Brivafutal 50 mg
Film Coated Tablets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Cetabrivara 50mg
Film Coated Tablets
🇪🇬EgyptRIVA PHARMAactive
Pilebriva 50 mg
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Brivasizur 50mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Brivasizur 50mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Pilebriva 50 mg
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Andolepsy 50 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Brivaralepsy 50 mg /5 ml
Solution for I.V injection \Infusion
🇪🇬EgyptPROTECH PHARMACEUTICAL COMPANYactive
Brivasizur
Solution for I.V injection \Infusion
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Andolepsy 50 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Convarsiotam 50mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Kativarox
Solution for I.V injection \Infusion
🇪🇬EgyptApex pharmaactive
Kativarox 50 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Brivaralepsy 50 mg /5 ml
Solution for I.V injection \Infusion
🇪🇬EgyptPROTECH PHARMACEUTICAL COMPANYactive

Brivaracetam 50 Mg ; in Africa — Regulatory Overview

Brivaracetam 50 Mg ; is registered across 1 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 15 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.